Nuvalent (NUVL) Non Operating Income (2020 - 2026)
Nuvalent (NUVL) posted Non Operating Income of $10.3 million for Q1 2026, down 73.53% on a QoQ basis from $38.9 million in Q4 2025, and down 0.88% year-over-year from $10.4 million in Q1 2025.
Nuvalent (NUVL) Non Operating Income (2020 - 2026) Analysis & Trends
Nuvalent's Non Operating Income history runs 7 years deep, the most recent figure standing at $10.3 million for Q1 2026.
- Quarterly Non Operating Income fell 0.88% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.7 million (up 114.64% YoY) and the FY2025 annual result came in at $44.7 million, up 16.75% from the prior year.
- Non Operating Income was $10.3 million for Q1 2026 at Nuvalent, down from $38.9 million in the prior quarter.
- Across five years, Non Operating Income topped out at $38.9 million in Q4 2025 and bottomed at -$9.6 million in Q3 2025.
- A 5-year average of $6.5 million and a median of $5.1 million in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 67100.0% — and 2024, when it tumbled 255.2%.
- Nuvalent's Non Operating Income stood at $3.2 million in 2022, then soared by 156.45% to $8.1 million in 2023, then surged by 60.18% to $13.0 million in 2024, then surged by 198.11% to $38.9 million in 2025, then sank by 73.53% to $10.3 million in 2026.
- Business Quant data shows NUVL's Non Operating Income at $10.3 million in Q1 2026, $38.9 million in Q4 2025, and -$9.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 10.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.30 Mn |
| Dec 31, 2025 | 38.89 Mn |
| Sep 30, 2025 | -9.61 Mn |
| Jun 30, 2025 | 11.10 Mn |
| Mar 31, 2025 | 10.39 Mn |
| Dec 31, 2024 | 13.05 Mn |
| Sep 30, 2024 | -7.97 Mn |
| Jun 30, 2024 | 8.15 Mn |
| Mar 31, 2024 | 8.49 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 5.14 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 5.02 Mn |
| Dec 31, 2022 | 3.18 Mn |
| Sep 30, 2022 | 672,000.00 |
| Jun 30, 2022 | 267,000.00 |
| Mar 31, 2022 | 139,000.00 |
| Dec 31, 2021 | 89,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 12,000.00 |